Kyowa Kirin stops development of skin condition treatment
Kyowa Kirin Regains Global Rights To Atopic Dermatitis Drug After Amgen Collaboration Ends
Kura Oncology to partner with Kyowa Kirin for blood cancer therapy
Kyowa Kirin's gene therapy most expensive US drug with $4.3 mln price tag
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln
Kyowa Kirin To Cut Royalty Payment Rate To Ardelyx For Tenapanor In Cardiorenal Disorders
MEI Pharma, Kyowa Kirin Reveal Data From Zandelisib Trial In Follicular Lymphoma